Literature DB >> 12039857

Enhancement of p53 activity and inhibition of neural cell proliferation by glucocorticoid receptor activation.

Christophe Crochemore1, Theologos M Michaelidis, Dieter Fischer, Jean-Philippe Loeffler, Osborne F X Almeida.   

Abstract

In analyzing the molecular mechanisms underlying glucocorticoid-induced apoptosis in neural cells, we observed that dexamethasone, by activating glucocorticoid receptors, causes arrest of HT-22 cells in the G1 phase of the cell cycle; upon withdrawal of the agonist, cells resume proliferation. Our investigations revealed that glucocorticoid treatment, although having no effects on endogenous p53 protein stability, induces rapid translocation of p53 to the nucleus and enhances its transcriptional activity. Consistently, transfection studies with p53-responsive promoters revealed a substantial stimulation of the trans-activation potential of exogenous p53 by dexamethasone. Cells arrested in G1 failed to show signs of apoptosis even after overexpression of p53. Although dexamethasone induced transcription of the proapoptotic gene bax, there was no increase of Bax protein levels. We conclude that glucocorticoid receptor-induced neural cell cycle arrest is associated with an increase in nuclear translocation and transcriptional activity of p53, and suggest that potentiation of p53 may serve as a brake on cell proliferation and may prime cells for differentiation or death induced by other signals.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12039857     DOI: 10.1096/fj.01-0577com

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  29 in total

1.  Zinc regulation of transcriptional activity during retinoic acid-induced neuronal differentiation.

Authors:  Deborah R Morris; Cathy W Levenson
Journal:  J Nutr Biochem       Date:  2013-09-09       Impact factor: 6.048

2.  Glucocorticoids exacerbate hypoxia-induced expression of the pro-apoptotic gene Bnip3 in the developing cortex.

Authors:  U S Sandau; R J Handa
Journal:  Neuroscience       Date:  2006-11-15       Impact factor: 3.590

Review 3.  Prenatal treatment of congenital adrenal hyperplasia-not standard of care.

Authors:  Selma Feldman Witchel; Walter L Miller
Journal:  J Genet Couns       Date:  2012-05-26       Impact factor: 2.537

4.  Mineralocorticoid receptor overexpression facilitates differentiation and promotes survival of embryonic stem cell-derived neurons.

Authors:  Mathilde Munier; Frédéric Law; Geri Meduri; Damien Le Menuet; Marc Lombès
Journal:  Endocrinology       Date:  2012-01-10       Impact factor: 4.736

5.  Epidermal FABP Prevents Chemical-Induced Skin Tumorigenesis by Regulation of TPA-Induced IFN/p53/SOX2 Pathway in Keratinocytes.

Authors:  Yuwen Zhang; Jiaqing Hao; Jun Zeng; Qiang Li; Enyu Rao; Yanwen Sun; Lianliang Liu; Anita Mandal; V Douglas Landers; Rebecca J Morris; Margot P Cleary; Jill Suttles; Bing Li
Journal:  J Invest Dermatol       Date:  2018-03-17       Impact factor: 8.551

6.  In vitro and in vivo roles of glucocorticoid and vitamin D receptors in the control of neonatal cardiomyocyte proliferative potential.

Authors:  Stephen Cutie; Alexander Y Payumo; Dominic Lunn; Guo N Huang
Journal:  J Mol Cell Cardiol       Date:  2020-04-11       Impact factor: 5.000

7.  Sex differences in cell proliferation and glucocorticoid responsiveness in the zebra finch brain.

Authors:  Amnon Katz; Anahid Mirzatoni; Yin Zhen; Barney A Schlinger
Journal:  Eur J Neurosci       Date:  2008-07       Impact factor: 3.386

8.  L-GILZ binds p53 and MDM2 and suppresses tumor growth through p53 activation in human cancer cells.

Authors:  E Ayroldi; M G Petrillo; A Bastianelli; M C Marchetti; S Ronchetti; G Nocentini; L Ricciotti; L Cannarile; C Riccardi
Journal:  Cell Death Differ       Date:  2014-08-29       Impact factor: 15.828

9.  Reconstitution of glucocorticoid receptor-dependent transcription in vivo.

Authors:  Kevin W Trotter; Trevor K Archer
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

10.  Glucocorticoid receptor status is a principal determinant of variability in the sensitivity of non-small-cell lung cancer cells to pemetrexed.

Authors:  Mugdha Patki; Shirish Gadgeel; Yanfang Huang; Thomas McFall; Anthony F Shields; Larry H Matherly; Gerold Bepler; Manohar Ratnam
Journal:  J Thorac Oncol       Date:  2014-04       Impact factor: 15.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.